Back to Search
DANIEL MCGOWAN, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1780667931IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
19175(NE)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
UNIVERSITY OF NEBRASKA COLLEGE OF MEDICINE
Class of 1992
Research & Publications (20)
Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.
PMID 19507864·J Med Chem·2009
8-other
Electroreception in the euryhaline stingray, Dasyatis sabina.
PMID 19411548·J Exp Biol·2009
7-preclinical
Who is responsible for the efficacy and safety of pet foods?
PMID 19119361·Can Vet J·2008
7-preclinical
Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
PMID 18954982·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors.
PMID 18722116·Bioorg Med Chem Lett·2008
7-preclinical
Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350.
PMID 18678486·Bioorg Med Chem Lett·2008
4-observational
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
PMID 18321037·J Med Chem·2008
7-preclinical
Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SAR.
PMID 17280833·Bioorg Med Chem Lett·2007
7-preclinical
Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties.
PMID 17276681·Bioorg Med Chem Lett·2007
7-preclinical
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase.
PMID 17253679·J Med Chem·2007
7-preclinical
Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease.
PMID 17100850·Eur J Neurosci·2006
7-preclinical
Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
PMID 16970394·J Med Chem·2006
7-preclinical
Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity.
PMID 16884310·J Med Chem·2006
7-preclinical
Mercury vapour levels in dental practices and body mercury levels of dentists and controls.
PMID 15611750·Br Dent J·2004
8-other
The effect of immunomodulatory treatment on multiple sclerosis fatigue.
PMID 15201369·J Neurol Neurosurg Psychiatry·2004
3-trial
Medical examiners, coroners, and biologic terrorism: a guidebook for surveillance and case management.
PMID 15192550·MMWR Recomm Rep·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3219 CENTRAL AVE, STE 111
KEARNEY, NE 68847 - Phone
- (402) 328-8833
Quick Facts
- NPI
- 1780667931
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile